Related Experiment Video

Updated: May 4, 2026

Author Spotlight: Decoding Mitochondrial Aging
08:48

Author Spotlight: Decoding Mitochondrial Aging

Published on: June 30, 2023

6.3K

Mildronate and its neuroregulatory mechanisms: targeting the mitochondria, neuroinflammation, and protein expression

Vija Klusa1, Ulrika Beitnere, Jolanta Pupure

  • 1Department of Pharmacology, Faculty of Medicine, University of Latvia, Raina blv. 19, 1586 Riga, Latvia. vijaklus@latnet.lv, vija.klusa@lu.lv.

Medicina (Kaunas, Lithuania)
|December 31, 2013
PubMed

Insights

Mildronate, a cardioprotective drug, shows significant neuroprotective effects in animal models. It regulates mitochondrial function and protein expression, enhancing learning, memory, and neurogenesis for neurological disorder treatment.

Area of Science:

  • Neuropharmacology
  • Neurobiology

Background:

  • Mildronate is primarily known as a cardioprotective agent.
  • Emerging evidence suggests potential neuroprotective roles for mildronate.

Purpose of the Study:

  • To review and summarize neuropharmacological studies on mildronate.
  • To elucidate the neuroprotective mechanisms and therapeutic potential of mildronate in neurological disorders.

Main Methods:

  • Review of existing neuropharmacological studies.
  • Inclusion of data from animal models of neurotoxicity and neurodegenerative diseases.
  • Analysis of immunohistochemical methods, Western blot, and behavioral tests.

Main Results:

  • Mildronate demonstrated neuroprotective activity across various animal models.
  • Identified mechanisms include regulation of mitochondrial processes and nerve cell protein expression involved in survival and inflammation.
  • Mildronate was shown to stimulate learning and memory, and affect proteins related to synaptic plasticity and neurogenesis.

Conclusions:

  • Mildronate exhibits significant neuroprotective and cognitive-enhancing properties.
  • Its mechanisms involve mitochondrial regulation and modulation of key neuronal proteins.
  • Mildronate holds promise for protecting and treating neurological disorders, especially those involving neurodegeneration and cognitive decline.

More Related Videos

Treating SCA1 Mice with Water-Soluble Compounds to Non-Specifically Boost Mitochondrial Function11:47

Treating SCA1 Mice with Water-Soluble Compounds to Non-Specifically Boost Mitochondrial Function

Published on: January 22, 2017

10.1K
Cholinergic Ligand–dependent Modulation of Oxidative Phosphorylation Coupling in Digitonin-permeabilized BE(2)-C Neuroblastoma Cells14:39

Cholinergic Ligand–dependent Modulation of Oxidative Phosphorylation Coupling in Digitonin-permeabilized BE(2)-C Neuroblastoma Cells

Published on: April 28, 2026

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
11.9K
Neurochemical Transmission: Sites of Drug Action01:26

Neurochemical Transmission: Sites of Drug Action

Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
3.5K
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.5K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.2K
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
926